Aiforia named as one of the 25 European medtech and life sciences start-ups to watch in 2019

Siliconrepublic.com - Aiforia was mentioned in Silicon Republic's Top 25 European medtech and life sciences start-ups to watch in 2019."Europe is in good health when it comes a diverse and innovative mix of medtech start-ups. These are the ones to watch in 2019.

From clever use of artificial intelligence (AI) by fusing it with apps on smart devices, to new ways of diagnosing and treating illnesses, European medtech and life sciences start-ups are pushing the innovation envelope further than ever thought possible.

As today’s crop of start-ups to watch indicates, technical excellence vies with imagination and business knowhow, culminating in a very switched-on cohort indeed.

This listing is part of our Europe Start-up 100 series for 2019, which every day this week has focused on a different list, including e-commerce and fintech, deep tech, and hardware and IoT start-ups. Tomorrow (25 January), we will publish our full Europe Start-up 100 list of the ones to watch.

Remember, these lists are not absolute because they are only a dip in the ocean of European innovation. As such, they are devised to give you a flavour of the kind of activity that is happening.And so, here are our 25 European medtech and life sciences start-ups to watch in 2019.Helsinki’s Aiforia, previously known as Fimmic, has developed an AI tissue diagnostics platform called WebMicroscope for virtual microscopy. Founded in 2013, the technology is designed to handle large, gigapixel-sized images of scanned tissues and biopsies. It was founded by Johan Lundin, Kari Pitkänen and Mikael Lundin and its CEO is Kaisa Helminen. It raised €5m in December 2017 in a funding round including Ascend Capital Partners, Acme Investments and Sto-Rahoitus."

Find the original article here: https://www.siliconrepublic.com/start-ups/european-medtech-life-sciences-entrepreneurs-2019